Company news

Invion Ltd. news in 2024

Invion Ltd.'s news releases, calls and decks from 2024, newest first.

View company

Invion Doses First Patient in Phase I/II Skin Cancer Trial

December 2, 2024

Consolidation/Split - IVX

October 14, 2024

Invion Limited (ASX: IVX) Prostate Cancer Trial Results

September 18, 2024

Ph 2 Prostate Cancer Results Strong Safety and 40% Response

September 17, 2024

Invion secures funding through an institutional placement

June 27, 2024

Agreement with Major South Korean Pharma Group Hanlim

May 7, 2024

INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC

March 4, 2024

Agreement with Dr.inB to develop Photosoft treatment for HPV

February 22, 2024

Decks in 2024